EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Discovery of a ROS-responsive dual-activity hydrogen sulfide donor against myocardial ischemia reperfusion injury

Rong-Hong Zhang, Long-Fa Yang, Yi-Ying Lian, Jin-Feng Long, Hong-Fu Liu, Yong-Long Zhao, Shang-Gao Liao, Yong-Jun Li, Dan Yang, Meng Zhou

European Journal of Pharmaceutical Sciences · 2026-12 · 227 · 107668

DOI: 10.1016/j.ejps.2026.107668 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutical Sciences, 2026-12. Verfasst von Rong-Hong Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Engineering Research Center for the Devel…. Hauptthemen laut MEDLINE: Hydrogen Sulfide, Reactive Oxygen Species, Myocardial Reperfusion Injury, Carbolines. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guizhou Medical University, National Natural Science Foundation of China, Guizhou Provincial Science and Technology Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myocardial ischemia-reperfusion injury (MIRI) is closely associated with excessive reactive oxygen species (ROS)-mediated oxidative stress, leading to severe cardiomyocyte and endothelial damage. Hydrogen sulfide (H2S) functions as a key cardioprotective gasotransmitter, yet the clinical translation of H2S donors has been limited by poor selectivity and low structural efficiency. To extend the bioactivity and structural utility of H2S donors, a series of dual-functional ROS-responsive H2S donors were designed by conjugating a cytoprotective β-carboline fragment with an H2O2-cleavable arylboronate ester-based H2S-donating trigger. The synthesized compounds (6a-6n) showed negligible cytotoxicity in H9c2 cardiomyoblasts and HUVECs. Among them, H2S donor 6m exhibited the most potent protective effect against H2O2-induced injury, restoring H9c2 cell viability to 84.75% and significantly improving HUVEC survival. Mechanistic studies confirmed that 6m undergoes H2O2-triggered cascade hydrolysis, resulting in the sustained co-release of H2S and the active β-carboline fragment (4m). In vitro mechanistic studies revealed that 6m attenuated cardiomyocyte apoptosis, enhanced the activities of endogenous antioxidant enzymes (SOD and GPx), and maintained mitochondrial membrane potential (ΔΨm). In a rat model of MIRI, 6m augmented myocardial antioxidant capacity, dose-dependently improved cardiac function, and reduced infarct size. These findings suggest that the dual-functional ROS-responsive H2S donor 6m exerts synergistic cardioprotective effects through ROS scavenging and H2S release, providing a promising therapeutic strategy for MIRI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydrogen SulfideReactive Oxygen SpeciesMyocardial Reperfusion InjuryCarbolinesCardiotonic AgentsAnimalsHumansRatsMaleRats, Sprague-DawleyCell LineHydrogen PeroxideMyocytes, CardiacHuman Umbilical Vein Endothelial CellsApoptosisCell SurvivalMembrane Potential, MitochondrialOxidative Stress

Stichwörter der Autor:innen

Dual-functionalH(2)O(2)Hydrogen sulfide donorOxidative injuryβ-Carboline

Substanzen

Hydrogen SulfideReactive Oxygen SpeciesHydrogen PeroxideCarbolinesCardiotonic Agents

Autor:innen und Institutionen

  • State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Educati…

Förderung

  • Guizhou Medical University
  • National Natural Science Foundation of China
  • Guizhou Provincial Science and Technology Department
  • Health Commission of Guizhou Province

Zitieren

APA

Zhang, R. H., Yang, L. F., Lian, Y. Y., Long, J. F., Liu, H. F., Zhao, Y. L., Liao, S. G., Li, Y. J., Yang, D., & Zhou, M. (2026). Discovery of a ROS-responsive dual-activity hydrogen sulfide donor against myocardial ischemia reperfusion injury. European Journal of Pharmaceutical Sciences, 227, 107668. https://doi.org/10.1016/j.ejps.2026.107668

Vancouver

Zhang RH, Yang LF, Lian YY, Long JF, Liu HF, Zhao YL, et al. Discovery of a ROS-responsive dual-activity hydrogen sulfide donor against myocardial ischemia reperfusion injury. European Journal of Pharmaceutical Sciences. 2026;227:107668. doi:10.1016/j.ejps.2026.107668

BibTeX
@article{Zhang2026,
  author = {Zhang, Rong-Hong and Yang, Long-Fa and Lian, Yi-Ying and Long, Jin-Feng and Liu, Hong-Fu and Zhao, Yong-Long and Liao, Shang-Gao and Li, Yong-Jun and Yang, Dan and Zhou, Meng},
  title = {Discovery of a ROS-responsive dual-activity hydrogen sulfide donor against myocardial ischemia reperfusion injury},
  journal = {European Journal of Pharmaceutical Sciences},
  year = {2026},
  volume = {227},
  pages = {107668},
  doi = {10.1016/j.ejps.2026.107668}
}
Kostenlos starten →